Report Detail
Global Hemophilia Treatment Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
- RnM2772964 |
- 17 January, 2019 |
- Global |
- 118 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
Hemophilia is a hereditary genetic disorder which impairs body’s ability to control coagulation or blood clotting. In this disease, clotting factors control bleeding from a broken vessel is deficient; therefore, coagulation does not occur. Of the two types of hemophilia, hemophilia A has higher prevalence compared to the other variant hemophilia B. . Acquired hemophilia is a rare non genetic form of hemophilia in which autoantibodies develop against the plasma coagulation factor. The development of novel coagulating factors and technological advancements are driving the growth of this market. Lack of available medicines, awareness of this disease and high cost of treatment are the major restraining factors in this market. The advancements in gene therapy and approaching approval of drugs for treatment of hemophilia provide growth opportunities in this market.
Scope of the Report:
This report focuses on the Hemophilia Treatment in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Hemophilia Treatment is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
CSL Behring
Baxalta
Pfizer Inc
BioMarin
Bayer Healthcare
Biogen
Novo Nordisk
Roche
Shire Plc
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
On-demand
prophylaxis
Market Segment by Applications, can be divided into
Replacement therapy
ITI therapy
Gene therapy
There are 15 Chapters to deeply display the global Hemophilia Treatment market.
Chapter 1, to describe Hemophilia Treatment Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Hemophilia Treatment, with sales, revenue, and price of Hemophilia Treatment, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Hemophilia Treatment, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Hemophilia Treatment market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Hemophilia Treatment sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Table of Contents
1 Market Overview
- 1.1 Hemophilia Treatment Introduction
- 1.2 Market Analysis by Type
- 1.2.1 On-demand
- 1.2.2 prophylaxis
- 1.3 Market Analysis by Applications
- 1.3.1 Replacement therapy
- 1.3.2 ITI therapy
- 1.3.3 Gene therapy
- 1.4 Market Analysis by Regions
- 1.4.1 North America (United States, Canada and Mexico)
- 1.4.1.1 United States Market States and Outlook (2013-2023)
- 1.4.1.2 Canada Market States and Outlook (2013-2023)
- 1.4.1.3 Mexico Market States and Outlook (2013-2023)
- 1.4.2 Europe (Germany, France, UK, Russia and Italy)
- 1.4.2.1 Germany Market States and Outlook (2013-2023)
- 1.4.2.2 France Market States and Outlook (2013-2023)
- 1.4.2.3 UK Market States and Outlook (2013-2023)
- 1.4.2.4 Russia Market States and Outlook (2013-2023)
- 1.4.2.5 Italy Market States and Outlook (2013-2023)
- 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- 1.4.3.1 China Market States and Outlook (2013-2023)
- 1.4.3.2 Japan Market States and Outlook (2013-2023)
- 1.4.3.3 Korea Market States and Outlook (2013-2023)
- 1.4.3.4 India Market States and Outlook (2013-2023)
- 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
- 1.4.4 South America, Middle East and Africa
- 1.4.4.1 Brazil Market States and Outlook (2013-2023)
- 1.4.4.2 Egypt Market States and Outlook (2013-2023)
- 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
- 1.4.4.4 South Africa Market States and Outlook (2013-2023)
- 1.4.4.5 Nigeria Market States and Outlook (2013-2023)
- 1.4.1 North America (United States, Canada and Mexico)
- 1.5 Market Dynamics
- 1.5.1 Market Opportunities
- 1.5.2 Market Risk
- 1.5.3 Market Driving Force
2 Manufacturers Profiles
- 2.1 CSL Behring
- 2.1.1 Business Overview
- 2.1.2 Hemophilia Treatment Type and Applications
- 2.1.2.1 Product A
- 2.1.2.2 Product B
- 2.1.3 CSL Behring Hemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
- 2.2 Baxalta
- 2.2.1 Business Overview
- 2.2.2 Hemophilia Treatment Type and Applications
- 2.2.2.1 Product A
- 2.2.2.2 Product B
- 2.2.3 Baxalta Hemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
- 2.3 Pfizer Inc
- 2.3.1 Business Overview
- 2.3.2 Hemophilia Treatment Type and Applications
- 2.3.2.1 Product A
- 2.3.2.2 Product B
- 2.3.3 Pfizer Inc Hemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
- 2.4 BioMarin
- 2.4.1 Business Overview
- 2.4.2 Hemophilia Treatment Type and Applications
- 2.4.2.1 Product A
- 2.4.2.2 Product B
- 2.4.3 BioMarin Hemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
- 2.5 Bayer Healthcare
- 2.5.1 Business Overview
- 2.5.2 Hemophilia Treatment Type and Applications
- 2.5.2.1 Product A
- 2.5.2.2 Product B
- 2.5.3 Bayer Healthcare Hemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
- 2.6 Biogen
- 2.6.1 Business Overview
- 2.6.2 Hemophilia Treatment Type and Applications
- 2.6.2.1 Product A
- 2.6.2.2 Product B
- 2.6.3 Biogen Hemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
- 2.7 Novo Nordisk
- 2.7.1 Business Overview
- 2.7.2 Hemophilia Treatment Type and Applications
- 2.7.2.1 Product A
- 2.7.2.2 Product B
- 2.7.3 Novo Nordisk Hemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
- 2.8 Roche
- 2.8.1 Business Overview
- 2.8.2 Hemophilia Treatment Type and Applications
- 2.8.2.1 Product A
- 2.8.2.2 Product B
- 2.8.3 Roche Hemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
- 2.9 Shire Plc
- 2.9.1 Business Overview
- 2.9.2 Hemophilia Treatment Type and Applications
- 2.9.2.1 Product A
- 2.9.2.2 Product B
- 2.9.3 Shire Plc Hemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Hemophilia Treatment Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
- 3.1 Global Hemophilia Treatment Sales and Market Share by Manufacturer (2016-2017)
- 3.2 Global Hemophilia Treatment Revenue and Market Share by Manufacturer (2016-2017)
- 3.3 Market Concentration Rate
- 3.3.1 Top 3 Hemophilia Treatment Manufacturer Market Share in 2017
- 3.3.2 Top 6 Hemophilia Treatment Manufacturer Market Share in 2017
- 3.4 Market Competition Trend
4 Global Hemophilia Treatment Market Analysis by Regions
- 4.1 Global Hemophilia Treatment Sales, Revenue and Market Share by Regions
- 4.1.1 Global Hemophilia Treatment Sales and Market Share by Regions (2013-2018)
- 4.1.2 Global Hemophilia Treatment Revenue and Market Share by Regions (2013-2018)
- 4.2 North America Hemophilia Treatment Sales and Growth Rate (2013-2018)
- 4.3 Europe Hemophilia Treatment Sales and Growth Rate (2013-2018)
- 4.4 Asia-Pacific Hemophilia Treatment Sales and Growth Rate (2013-2018)
- 4.5 South America Hemophilia Treatment Sales and Growth Rate (2013-2018)
- 4.6 Middle East and Africa Hemophilia Treatment Sales and Growth Rate (2013-2018)
5 North America Hemophilia Treatment by Countries
- 5.1 North America Hemophilia Treatment Sales, Revenue and Market Share by Countries
- 5.1.1 North America Hemophilia Treatment Sales and Market Share by Countries (2013-2018)
- 5.1.2 North America Hemophilia Treatment Revenue and Market Share by Countries (2013-2018)
- 5.2 United States Hemophilia Treatment Sales and Growth Rate (2013-2018)
- 5.3 Canada Hemophilia Treatment Sales and Growth Rate (2013-2018)
- 5.4 Mexico Hemophilia Treatment Sales and Growth Rate (2013-2018)
6 Europe Hemophilia Treatment by Countries
- 6.1 Europe Hemophilia Treatment Sales, Revenue and Market Share by Countries
- 6.1.1 Europe Hemophilia Treatment Sales and Market Share by Countries (2013-2018)
- 6.1.2 Europe Hemophilia Treatment Revenue and Market Share by Countries (2013-2018)
- 6.2 Germany Hemophilia Treatment Sales and Growth Rate (2013-2018)
- 6.3 UK Hemophilia Treatment Sales and Growth Rate (2013-2018)
- 6.4 France Hemophilia Treatment Sales and Growth Rate (2013-2018)
- 6.5 Russia Hemophilia Treatment Sales and Growth Rate (2013-2018)
- 6.6 Italy Hemophilia Treatment Sales and Growth Rate (2013-2018)
7 Asia-Pacific Hemophilia Treatment by Countries
- 7.1 Asia-Pacific Hemophilia Treatment Sales, Revenue and Market Share by Countries
- 7.1.1 Asia-Pacific Hemophilia Treatment Sales and Market Share by Countries (2013-2018)
- 7.1.2 Asia-Pacific Hemophilia Treatment Revenue and Market Share by Countries (2013-2018)
- 7.2 China Hemophilia Treatment Sales and Growth Rate (2013-2018)
- 7.3 Japan Hemophilia Treatment Sales and Growth Rate (2013-2018)
- 7.4 Korea Hemophilia Treatment Sales and Growth Rate (2013-2018)
- 7.5 India Hemophilia Treatment Sales and Growth Rate (2013-2018)
- 7.6 Southeast Asia Hemophilia Treatment Sales and Growth Rate (2013-2018)
8 South America Hemophilia Treatment by Countries
- 8.1 South America Hemophilia Treatment Sales, Revenue and Market Share by Countries
- 8.1.1 South America Hemophilia Treatment Sales and Market Share by Countries (2013-2018)
- 8.1.2 South America Hemophilia Treatment Revenue and Market Share by Countries (2013-2018)
- 8.2 Brazil Hemophilia Treatment Sales and Growth Rate (2013-2018)
- 8.3 Argentina Hemophilia Treatment Sales and Growth Rate (2013-2018)
- 8.4 Colombia Hemophilia Treatment Sales and Growth Rate (2013-2018)
9 Middle East and Africa Hemophilia Treatment by Countries
- 9.1 Middle East and Africa Hemophilia Treatment Sales, Revenue and Market Share by Countries
- 9.1.1 Middle East and Africa Hemophilia Treatment Sales and Market Share by Countries (2013-2018)
- 9.1.2 Middle East and Africa Hemophilia Treatment Revenue and Market Share by Countries (2013-2018)
- 9.2 Saudi Arabia Hemophilia Treatment Sales and Growth Rate (2013-2018)
- 9.3 UAE Hemophilia Treatment Sales and Growth Rate (2013-2018)
- 9.4 Egypt Hemophilia Treatment Sales and Growth Rate (2013-2018)
- 9.5 Nigeria Hemophilia Treatment Sales and Growth Rate (2013-2018)
- 9.6 South Africa Hemophilia Treatment Sales and Growth Rate (2013-2018)
10 Global Hemophilia Treatment Market Segment by Type
- 10.1 Global Hemophilia Treatment Sales, Revenue and Market Share by Type (2013-2018)
- 10.1.1 Global Hemophilia Treatment Sales and Market Share by Type (2013-2018)
- 10.1.2 Global Hemophilia Treatment Revenue and Market Share by Type (2013-2018)
- 10.2 On-demand Sales Growth and Price
- 10.2.1 Global On-demand Sales Growth (2013-2018)
- 10.2.2 Global On-demand Price (2013-2018)
- 10.3 prophylaxis Sales Growth and Price
- 10.3.1 Global prophylaxis Sales Growth (2013-2018)
- 10.3.2 Global prophylaxis Price (2013-2018)
11 Global Hemophilia Treatment Market Segment by Application
- 11.1 Global Hemophilia Treatment Sales Market Share by Application (2013-2018)
- 11.2 Replacement therapy Sales Growth (2013-2018)
- 11.3 ITI therapy Sales Growth (2013-2018)
- 11.4 Gene therapy Sales Growth (2013-2018)
12 Hemophilia Treatment Market Forecast (2018-2023)
- 12.1 Global Hemophilia Treatment Sales, Revenue and Growth Rate (2018-2023)
- 12.2 Hemophilia Treatment Market Forecast by Regions (2018-2023)
- 12.2.1 North America Hemophilia Treatment Market Forecast (2018-2023)
- 12.2.2 Europe Hemophilia Treatment Market Forecast (2018-2023)
- 12.2.3 Asia-Pacific Hemophilia Treatment Market Forecast (2018-2023)
- 12.2.4 South America Hemophilia Treatment Market Forecast (2018-2023)
- 12.2.5 Middle East and Africa Hemophilia Treatment Market Forecast (2018-2023)
- 12.3 Hemophilia Treatment Market Forecast by Type (2018-2023)
- 12.3.1 Global Hemophilia Treatment Sales Forecast by Type (2018-2023)
- 12.3.2 Global Hemophilia Treatment Market Share Forecast by Type (2018-2023)
- 12.4 Hemophilia Treatment Market Forecast by Application (2018-2023)
- 12.4.1 Global Hemophilia Treatment Sales Forecast by Application (2018-2023)
- 12.4.2 Global Hemophilia Treatment Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
- 13.1 Sales Channel
- 13.1.1 Direct Marketing
- 13.1.2 Indirect Marketing
- 13.1.3 Marketing Channel Future Trend
- 13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
- 15.1 Methodology
Summary:
Get latest Market Research Reports on Hemophilia Treatment . Industry analysis & Market Report on Hemophilia Treatment is a syndicated market report, published as Global Hemophilia Treatment Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Hemophilia Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
